Bhasin Tejinder Singh, Mannan Rahul, Manjari Mridu, Mehra Monica, Gill Sekhon Amarinder K, Chandey Manish, Sharma Sonam, Kaur Parampreet
Associate Professor, Department of Pathology, Sri Guru Ram Das Institute of Medical Sciences and Research , Amritsar, Punjab, India .
J Clin Diagn Res. 2013 Jun;7(6):1051-4. doi: 10.7860/JCDR/2013/5754.3087. Epub 2013 Jun 1.
To achieve the standardization of the thyroid FNA reporting, the National Cancer Institute (NCI) hosted the "NCI Thyroid Fine Needle Aspiration State of the Science Conference", which led to the formation of 'The Bethesda System for Reporting Thyroid Cytopathology' (TBSRTC).
The present study was undertaken by 2 experts in thyroid FNA, who in a double blinded fashion, examined and re-classified 80 random FNA cases according to the 6 levels of TBSRTC for an inter-observer review, to study and assess the new terminology for ease of reproducibility and to note the rate of disagreement overall or in any particular category. The FNAs were reclassified in a double blinded fashion according to the 6 levels of TBSRTC which are: non diagnostic (ND); benign; atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS); follicular neoplasm/suspicious for a follicular neoplasm (FN/SFN), Hurthle cell type/suspicious for a follicular neoplasm, Hurthle cell type (FNHCT/SFNHCT); suspicious (SUS), and malignant.
In the present study, the maximum number of cases was reclassified under the benign category (61.25% cases), followed by the FN/ SFN category and the AUS/FLUS category (11.25% and 10.00% respectively). An agreement was reached in 66 cases (82.5%); the experts disagreed in 14 cases-17.5% (where 1 expert did not agree with the other). Individually; a 93.87% agreement was noted for the lesions in the benign category, for 50% lesions in the AUS/FLUS category, for 66.66% lesions in the FN/SFN and the SUS categories, for 71.42% lesions in the FNHCT/ SFNHCT categories and for 100% lesions in the ND and the malignant categories. Thus, the maximum disagreement was noted in the AUS/FLUS category.
The implementation of TBSTRC which stands for a unique, international and a universal terminology for reporting the thyroid cytology; should be encouraged in our country, because of its relative ease of reproducibility. Although there was a great deal of agreement in implementing TBSTRC in the present study; disagreements were seen in the categories of AUS/FLUS and FN/SFN in the study which was conducted at our centre. This corroborated with the findings of the studies which were done elsewhere.
为实现甲状腺细针穿刺活检(FNA)报告的标准化,美国国立癌症研究所(NCI)主办了“NCI甲状腺细针穿刺科学现状会议”,由此形成了“甲状腺细胞病理学报告贝塞斯达系统”(TBSRTC)。
本研究由2名甲状腺FNA专家进行,他们以双盲方式,根据TBSRTC的6个级别对80例随机抽取的FNA病例进行检查和重新分类,以进行观察者间评估,研究和评估新术语的可重复性,并记录总体或任何特定类别的分歧率。FNA根据TBSRTC的6个级别以双盲方式重新分类,这6个级别分别为:无法诊断(ND);良性;意义不明确的非典型病变/意义不明确的滤泡性病变(AUS/FLUS);滤泡性肿瘤/可疑滤泡性肿瘤(FN/SFN),许特耳细胞型/可疑滤泡性肿瘤,许特耳细胞型(FNHCT/SFNHCT);可疑(SUS),以及恶性。
在本研究中,重新分类到良性类别的病例数量最多(61.25%),其次是FN/SFN类别和AUS/FLUS类别(分别为11.25%和10.00%)。66例(82.5%)达成了一致意见;专家们在14例病例上存在分歧——占17.5%(其中1名专家与另一名专家意见不同)。就单个类别而言;良性类别病变的一致率为93.87%,AUS/FLUS类别病变的一致率为50%,FN/SFN和SUS类别病变的一致率为66.66%,FNHCT/SFNHCT类别病变的一致率为71.42%,ND和恶性类别病变的一致率为100%。因此,AUS/FLUS类别中的分歧最大。
应在我国鼓励实施代表甲状腺细胞学报告独特、国际通用术语的TBSTRC,因为它相对易于重复。尽管在本研究中实施TBSTRC时达成了大量共识;但在我们中心进行的研究中,AUS/FLUS和FN/SFN类别中仍存在分歧。这与其他地方进行的研究结果相符。